FDA’s Message To Patient Advocates: Efforts On Engagement Are Only The Beginning

Food & Drug Administration officials used a day-long public meeting to reassure patient advocates that the agency’s efforts to enhance patient engagement in the drug development process have only just begun, and that many more steps will need to be taken before FDA can deem patient-focused drug development a complete success.